Workflow
argenx(ARGX) - 2025 Q4 - Earnings Call Presentation
2026-02-26 13:30
Certain statements contained in this presentation, other than present and historical facts and conditions independently verifiable at the date hereof, may constitute forward-looking statements. These forward-looking statements can be identified by the use of forward-looking terminology, including the terms "advance," "broaden," "build," "deliver," and "expand," and include statements argenx makes regarding its new era of innovation in immunology; its advancement of its Vision 2030, including (1) 5 new molec ...
Playtika(PLTK) - 2025 Q4 - Earnings Call Presentation
2026-02-26 13:30
February 26, 2026 LEGAL DISCLAIMER Forward-Looking Statements This presentation contains "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and Section 21E of the Exchange Act. All statements other than statements of historical facts contained in this presentation, including statements regarding our business strategy, plans and our objectives for future operations, are forward-looking statements. Further, statements that include words such as "antici ...
Bentley(BSY) - 2025 Q4 - Earnings Call Presentation
2026-02-26 13:15
© 2026 Bentley Systems, Incorporated. All rights reserved. 1 February 26, 2026 Perspectives from the Executive Chair 01 Perspectives from the CEO 02 Perspectives from the CFO Q&A 03 04 © 2026 Bentley Systems, Incorporated. All rights reserved. 2 Agenda Disclaimer BSY fourth quarter and full year 2025 results and 2026 financial outlook This presentation includes forward-looking statements regarding the future results of operations and financial position, business strategy, and plans and objectives for future ...
Collegium Pharmaceutical(COLL) - 2025 Q4 - Earnings Call Presentation
2026-02-26 13:00
Q4 and FY2025 Earnings Report February 26, 2026 | Nasdaq: COLL In this presentation, we discuss the following financial measures that are not calculated in accordance with GAAP, to supplement our consolidated financial statements presented on a GAAP basis. Adjusted EBITDA Adjusted EBITDA is a non-GAAP financial measure that represents GAAP net income or loss adjusted to exclude interest expense, interest income, the benefit from or provision for income taxes, depreciation, amortization, stock-based compensa ...
PROCEPT BioRobotics (NasdaqGM:PRCT) 2026 Earnings Call Presentation
2026-02-26 13:00
Welcome to 2026 Analyst Day Matt Bacso VP, Investor Relations © 2026 PROCEPT BioRobotics Corporation. All Rights Reserved. 1 This presentation and the accompanying oral presentation also contain estimates and other statistical data made by independent parties and by us relating to market size and growth and other data about performance and the future performance of the markets in which we compete are necessarily subject to a high degree of uncertainty and risk. Exchange Commission ("SEC"), including the Ann ...
Lantheus Holdings(LNTH) - 2025 Q4 - Earnings Call Presentation
2026-02-26 13:00
© 2026 Lantheus. All rights reserved. Agenda Lantheus Fourth Quarter & Full Year 2025 Results FEBRUARY 26, 2026 Highlights and Business Update Commercial Update Financial Update Closing Remarks Q&A SPEAKERS Mary Anne Heino Executive Board Chair & CEO © 2026 Lantheus. All rights reserved. 2 Bob Marshall CFO and Treasurer Amanda Morgan Chief Commercial Officer Mark Kinarney Vice President, Investor Relations Safe Harbor Statements Cautionary Statement Regarding Forward-Looking Statements This document contain ...
Opera(OPRA) - 2025 Q4 - Earnings Call Presentation
2026-02-26 13:00
Q4 2025 INVESTOR PRESENTATION OPERA February 2026 OPERA INVESTOR PRESENTATION / 2 February 2026 SAFE HARBOR STATEMENT & DISCLAIMERS This presentation has been prepared by Opera Limited (the "Company") for investors, solely for informational purposes. This presentation contains "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the Private Securities Litigation Reform A ...
Rhythm(RYTM) - 2025 Q4 - Earnings Call Presentation
2026-02-26 13:00
On Today's Call Rhythm Pharmaceuticals Fourth Quarter and Year End 2025 Financial Results and Business Update February 26, 2026 ® © Rhythm® Pharmaceuticals, Inc. All rights reserved. ® 2 • David Connolly, Executive Director of Investor Relations and Corporate Communications • David Meeker, MD, Chair, President and Chief Executive Officer • Jennifer Lee, Executive Vice President, Head of North America • Yann Mazabraud, Executive Vice President, Head of International • Hunter Smith, Chief Financial Officer Fo ...
Marriott Vacations Worldwide(VAC) - 2025 Q4 - Earnings Call Presentation
2026-02-26 13:00
Investor Presentation Forward-Looking Statements February 26, 2026 Forward-looking statements include all statements that are not historical facts and can be identified by the use of forward-looking terminology such as the words "believe," "expect," "plan," "intend," "anticipate," "estimate," "predict," "potential," "continue," "may," "might," "should," "could" or the negative of these terms or similar expressions. We caution you that these statements are not guarantees of future performance and are subject ...
Millicom(TIGO) - 2025 Q4 - Earnings Call Presentation
2026-02-26 13:00
Safe Harbor Q4 2025 Earnings Presentation Cautionary Language Concerning Forward-Looking Statements Statements included herein that are not historical facts, including without limitation statements concerning future strategy, plans, objectives, expectations and intentions, projected financial results, liquidity, growth and prospects, are forward-looking statements. Such forward-looking statements involve a number of risks and uncertainties and are subject to change at any time. In the event such risks or un ...